Pharmacological interventions for co-occurring psychopathology in people with borderline personality disorder: secondary analysis of the Cochrane systematic review with meta-analyses
The British Journal of Psychiatry · 2025-04 · 226 (4) · 226-237
DOI: 10.1192/bjp.2024.172 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The British Journal of Psychiatry, online erschienen am 21.10.2024. Verfasst von Johanne Pereira Ribeiro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Evidence-Based Psychiatry, Psychiatric Research Unit, Psychiatry Region Zealand, Slagelse, Denmark; and Department of Psychology, Universi…. Hauptthemen laut MEDLINE: Borderline Personality Disorder. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Medications are commonly used to treat co-occurring psychopathology in persons with borderline personality disorder (BPD)
Aims
To systematically review and integrate the evidence of medications for treatment of co-occurring psychopathology in people with BPD, and explore the role of comorbidities.
Method
Building on the current Cochrane review of medications in BPD, an update literature search was done in March 2024. We followed the methods of this Cochrane review, but scrutinised all identified placebo-controlled trials post hoc for reporting of non BPD-specific (‘co-occurring’) psychopathology, and explored treatment effects in subgroups of samples with and without defined co-occurring disorders. GRADE ratings were done to assess the evidence certainty.
Results
Twenty-two trials were available for quantitative analyses. For antipsychotics, we found very-low-certainty evidence (VLCE) of an effect on depressive symptoms (standardised mean difference (SMD) −0.22, P = 0.04), and low-certainty evidence (LCE) of an effect on psychotic–dissociative symptoms (SMD −0.28, P = 0.007). There was evidence of effects of anticonvulsants on depressive (SMD −0.44, P = 0.02; LCE) and anxious symptoms (SMD −1.11, P < 0.00001; VLCE). For antidepressants, no significant findings were observed (VLCE). Exploratory subgroup analyses indicated a greater effect of antipsychotics in samples including participants with co-occurring substance use disorders on psychotic–dissociative symptoms ( P = 0.001).
Conclusions
Our findings, based on VLCE and LCE only, do not support the use of pharmacological interventions in people with BPD to target co-occurring psychopathology. Overall, the current evidence does not support differential treatment effects in persons with versus without defined comorbidities. Medications should be used cautiously to target co-occurring psychopathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Evidence-Based Psychiatry, Psychiatric Research Unit, Psychiatry Region Zealand, Slagelse, Denmark; and Department of Psychology, University of Southern Denmark, Odense, Denmark.
- Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region of Denmark, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; and Stolpegaard Psychotherapy Centre, Mental Health…
- Department of Psychology, University of Southern Denmark, Odense, Denmark; and Mental Health Services West, Psychiatry Region Zealand, Slagelse, Denmark.
- Center for Evidence-Based Psychiatry, Psychiatric Research Unit, Psychiatry Region Zealand, Slagelse, Denmark.
- Department for Forensic Psychiatry, University Medicine Rostock, Rostock, Germany.
- Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK.
ORCID-Profile: Johanne Pereira Ribeiro, Sophie Juul, Mickey T Kongerslev, Mie Sedoc Jørgensen, Birgit A Völlm, Henriette Edemann-Callesen, Christian Sales, Julie P Schaug, Klaus Lieb, Erik Simonsen, Jutta M Stoffers-Winterling, Ole Jakob Storebø
Zitieren
APA
Pereira Ribeiro, J., Juul, S., Kongerslev, M. T., Jørgensen, M. S., Völlm, B. A., Edemann-Callesen, H., Sales, C., Schaug, J. P., Lieb, K., Simonsen, E., Stoffers-Winterling, J. M., & Storebø, O. J. (2025). Pharmacological interventions for co-occurring psychopathology in people with borderline personality disorder: secondary analysis of the Cochrane systematic review with meta-analyses. The British Journal of Psychiatry, 226(4), 226-237. https://doi.org/10.1192/bjp.2024.172
Vancouver
Pereira Ribeiro J, Juul S, Kongerslev MT, Jørgensen MS, Völlm BA, Edemann-Callesen H, et al. Pharmacological interventions for co-occurring psychopathology in people with borderline personality disorder: secondary analysis of the Cochrane systematic review with meta-analyses. The British Journal of Psychiatry. 2025;226(4):226-237. doi:10.1192/bjp.2024.172
BibTeX
@article{PereiraRibeiro2025,
author = {Pereira Ribeiro, Johanne and Juul, Sophie and Kongerslev, Mickey T and Jørgensen, Mie Sedoc and Völlm, Birgit A and Edemann-Callesen, Henriette and Sales, Christian and Schaug, Julie P and Lieb, Klaus and Simonsen, Erik and Stoffers-Winterling, Jutta M and Storebø, Ole Jakob},
title = {Pharmacological interventions for co-occurring psychopathology in people with borderline personality disorder: secondary analysis of the Cochrane systematic review with meta-analyses},
journal = {The British Journal of Psychiatry},
year = {2025},
volume = {226},
number = {4},
pages = {226--237},
doi = {10.1192/bjp.2024.172}
}
EUVIMED